c-KIT and PDGFRA in breast phyllodes tumours: Overexpression without mutations?

Journal of Clinical Pathology

Volumn 57, Issue 10, 2004, Pages 1075-1079

  Carvalho, S ^a   E Silva, A O ^b   Milanezi, F ^c   Ricardo, S ^a   Leitao D ^a   Amendoeira, I ^b   Schmitt, F C ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR;

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CLINICAL ARTICLE; CYSTOSARCOMA PHYLLOIDES; EXON; GASTROINTESTINAL TUMOR; GENE INSERTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PHYLLODES TUMOR; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 4944227056     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.016378     Document Type: Article

References (22)

1. Mol C, Lim K, Sridhar V, et al. Structure of c-KIT product complex reveals the basis for kinase transactivation. J Biol Chem 2003;278:31461-4.
2. Williams DE, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-74.
3. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the SI locus of the mouse and is ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:214-24.
4. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study of formalin-fixed, paraffin embedded tissues. Virchows Arch 1994;424:135-41.
5. Maeda H, Yamagata A, Nishikawa S, et al. Requirement of c-kit for development of intestinal pacemaker system. Development 1992;116:369-75.
6. Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet derived growth factor receptor beta. N Engl J Med 2002;347:481-7.
7. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
8. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61:8118-21.
9. Lux ML, Rubin BP, Biase TL, et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000;156:791-5.
10. Heinrich MC, Corless CL, Duensing A, et al, PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-10.
11. Tavassoli FA, Devilee P. Tumours of the breast. In: Pathology and genetics-tumours of the breast and female genital organs. WHO classification of tumours. Lyon: IARC Press, 2003:101-3.
12. Reis-Filho JS, Albergaria A, Milanezi F, et al. Naked nuclei revisited: p63 immunoexpression. Diagn Cytopathol 2002;27:135-8.
13. Reis-Filho JS, Milanezi F, Amendoeira J, et al. P63 staining of myoepithelial cells in fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol 2002;55:936-9.
14. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol 2002;26:493-7.
15. Corless CL, McGreevey L, Haley A, et al. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002;160:1567-72.
16. Chen CM, Chen CJ, Chang CL, et al. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res 2000;94:84-91.
17. Sawyer EJ, Poulsom R, Hunt FT, et al. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J Pathol 2003;200:59-64.
18. Sawyer EJ, Hanby AM, Ellis P, et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol 2000;156:1093-8.
19. Millar EKA, Beretov J, Marr P, et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology 1999;34:491-6.
20. Kracht J, Sapino A, Bussolati G. Malignant phyllodes tumours of breast with lung metastasis mimicking the primary. Am J Surg Pathol 1998;22:1284-90.
21. Ko CD, Kim JS, Ko BG, et al. The meaning of the c-KIT proto-oncogene product in malignant transformation in human mammary epithelium. Clin Exp Metastasis 2003;20:593-7.
22. Tse GMK, Lui PCW, Lo AWI, et al. Increased c-kit expression in malignant mammary phyllodes tumours [abstract]. Mod Pathol 2003;17:204.